Literature DB >> 35404007

HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies.

Edward F Kreider1, Katharine J Bar2.   

Abstract

PURPOSE OF REVIEW: Despite suppressive antiretroviral therapy (ART), a viral reservoir persists in individuals living with HIV that can reignite systemic replication should treatment be interrupted. Understanding how HIV-1 persists through effective ART is essential to develop cure strategies to induce ART-free virus remission. RECENT
FINDINGS: The HIV-1 reservoir resides in a pool of CD4-expressing cells as a range of viral species, a subset of which is genetically intact. Recent studies suggest that the reservoir on ART is highly dynamic, with expansion and contraction of virus-infected cells over time. Overall, the intact proviral reservoir declines faster than defective viruses, suggesting enhanced immune clearance or cellular turnover. Upon treatment interruption, rebound viruses demonstrate escape from adaptive and innate immune responses, implicating these selective pressures in restriction of virus reactivation. Cure strategies employing immunotherapy are poised to test whether host immune pressure can be augmented to enhance reservoir suppression or clearance. Alternatively, genomic engineering approaches are being applied to directly eliminate intact viruses and shrink the replication-competent virus pool. New evidence suggests host immunity exerts selective pressure on reservoir viruses and clears HIV-1 infected cells over years on ART. Efforts to build on the detectable, but insufficient, reservoir clearance via empiric testing in clinical trials will inform our understanding of mechanisms of viral persistence and the direction of future cure strategies.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cure; HIV-1 reservoirs; Persistence; Viral rebound

Mesh:

Substances:

Year:  2022        PMID: 35404007     DOI: 10.1007/s11904-022-00604-2

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.495


  137 in total

1.  HIV-1 latent reservoir size and diversity are stable following brief treatment interruption.

Authors:  D Brenda Salantes; Yu Zheng; Felicity Mampe; Tuhina Srivastava; Subul Beg; Jun Lai; Jonathan Z Li; Randall L Tressler; Richard A Koup; James Hoxie; Mohamed Abdel-Mohsen; Scott Sherrill-Mix; Kevin McCormick; E Turner Overton; Frederic D Bushman; Gerald H Learn; Robert F Siliciano; Janet M Siliciano; Pablo Tebas; Katharine J Bar
Journal:  J Clin Invest       Date:  2018-06-18       Impact factor: 14.808

Review 2.  Tenofovir and bone health.

Authors:  Philip M Grant; Aoife G Cotter
Journal:  Curr Opin HIV AIDS       Date:  2016-05       Impact factor: 4.283

Review 3.  Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses.

Authors:  Patrick S Sullivan; Anna Satcher Johnson; Elizabeth S Pembleton; Rob Stephenson; Amy C Justice; Keri N Althoff; Heather Bradley; Amanda D Castel; Alexandra M Oster; Eli S Rosenberg; Kenneth H Mayer; Chris Beyrer
Journal:  Lancet       Date:  2021-02-19       Impact factor: 79.321

4.  Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.

Authors:  Alison J Rodger; Rebecca Lodwick; Mauro Schechter; Steven Deeks; Janaki Amin; Richard Gilson; Roger Paredes; Elzbieta Bakowska; Frederik N Engsig; Andrew Phillips
Journal:  AIDS       Date:  2013-03-27       Impact factor: 4.177

5.  The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption.

Authors:  Jonathan Z Li; Behzad Etemad; Hayat Ahmed; Evgenia Aga; Ronald J Bosch; John W Mellors; Daniel R Kuritzkes; Michael M Lederman; Michael Para; Rajesh T Gandhi
Journal:  AIDS       Date:  2016-01-28       Impact factor: 4.177

6.  HIV persists throughout deep tissues with repopulation from multiple anatomical sources.

Authors:  Antoine Chaillon; Sara Gianella; Simon Dellicour; Stephen A Rawlings; Timothy E Schlub; Michelli Faria De Oliveira; Caroline Ignacio; Magali Porrachia; Bram Vrancken; Davey M Smith
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

7.  Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.

Authors:  Ya-Chi Ho; Liang Shan; Nina N Hosmane; Jeffrey Wang; Sarah B Laskey; Daniel I S Rosenbloom; Jun Lai; Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  Cell       Date:  2013-10-24       Impact factor: 41.582

Review 8.  Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment-Clinical Points of View and Practical Considerations.

Authors:  Simona A Iacob; Diana G Iacob; Gheorghita Jugulete
Journal:  Front Pharmacol       Date:  2017-11-23       Impact factor: 5.810

9.  Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016.

Authors:  Julia L Marcus; Wendy A Leyden; Stacey E Alexeeff; Alexandra N Anderson; Rulin C Hechter; Haihong Hu; Jennifer O Lam; William J Towner; Qing Yuan; Michael A Horberg; Michael J Silverberg
Journal:  JAMA Netw Open       Date:  2020-06-01
View more
  3 in total

Review 1.  HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency.

Authors:  Raquel Crespo; Shringar Rao; Tokameh Mahmoudi
Journal:  Front Cell Infect Microbiol       Date:  2022-06-14       Impact factor: 6.073

2.  Identification, Quantification, and Characterization of HIV-1 Reservoirs in the Human Brain.

Authors:  Maribel Donoso; Daniela D'Amico; Silvana Valdebenito; Cristian A Hernandez; Brendan Prideaux; Eliseo A Eugenin
Journal:  Cells       Date:  2022-08-02       Impact factor: 7.666

3.  Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies.

Authors:  Jord C Stam; Steven de Maat; Dorien de Jong; Mathia Arens; Fenna van Lint; Lavina Gharu; Mark H van Roosmalen; Rob C Roovers; Nika M Strokappe; Ralf Wagner; Alexander Kliche; Hans J de Haard; Paul M van Bergen En Henegouwen; Monique Nijhuis; C Theo Verrips
Journal:  Sci Rep       Date:  2022-08-04       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.